India's pharmaceutical exports are projected to reach US$ 350 billion by 2047, driven by specialty generics, biosimilars, and APIs.
At recent prices, you can buy shares of Merck (NYSE: MRK) that offer a yield above 3%, and shares of Pfizer (NYSE: PFE) offer ...
The global pharmaceutical industry is valued at approximately $1.6 trillion, while India's market stands at $55 billion, ...
KR Choksey is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1591 in its ...
After registering a net profit of Rs 25.1 crore in Q3FY25 and consolidated revenues growing by 7 per cent on a like-for-like ...
Pharmaceutical Market Size and Growth 2025 to 2034The global pharmaceutical market size was valued at USD 1,607.07 billion in ...
Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will recover. That isn't the case for many companies that have lagged broader ...
Norlase today announced the appointment of Jacob Philipsen, CEO of Advalight and co-founder of Norlase, as the new Chairman of the Board of Directors. Dr. Philipsen served as a board member prior to ...
“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...
Xtressétm, a pioneering company in hair and scalp therapy, officially launches today, backed by a team of the nation's leading dermatologists and hair restoration experts with over 180 years of ...
Nandita Vijayasimha, Bengaluru Monday, February 10, 2025, 08:00 Hrs [IST] ...
Shares in Pliant Therapeutics plunged in after-hours trading after the US biotech revealed that it has paused a phase 2b/3 trial of its lead drug for idiopathic pulmonary fibrosis (IPF) after seeing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results